{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T12:54:52Z","timestamp":1775134492173,"version":"3.50.1"},"reference-count":133,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T00:00:00Z","timestamp":1739404800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Bioinform."],"abstract":"<jats:p>Antibodies are naturally produced safeguarding proteins that the immune system generates to fight against invasive invaders. For centuries, they have been produced artificially and utilized to eradicate various infectious diseases. Given the ongoing threat posed by COVID-19 pandemics worldwide, antibodies have become one of the most promising treatments to prevent infection and save millions of lives. Currently, <jats:italic>in silico<\/jats:italic> techniques provide an innovative approach for developing antibodies, which significantly impacts the formulation of antibodies. These techniques develop antibodies with great specificity and potency against diseases such as SARS-CoV-2 by using computational tools and algorithms. Conventional methods for designing and developing antibodies are frequently costly and time-consuming. However, <jats:italic>in silico<\/jats:italic> approach offers a contemporary, effective, and economical paradigm for creating next-generation antibodies, especially in accordance with recent developments in bioinformatics. By utilizing multiple antibody databases and high-throughput approaches, a unique antibody construct can be designed <jats:italic>in silico<\/jats:italic>, facilitating accurate, reliable, and secure antibody development for human use. Compared to their traditionally developed equivalents, a large number of <jats:italic>in silico<\/jats:italic>-designed antibodies have advanced swiftly to clinical trials and became accessible sooner. This article helps researchers develop SARS-CoV-2 antibodies more quickly and affordably by giving them access to current information on computational approaches for antibody creation.<\/jats:p>","DOI":"10.3389\/fbinf.2025.1533983","type":"journal-article","created":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T07:08:52Z","timestamp":1739430532000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Unlocking the potential of in silico approach in designing antibodies against SARS-CoV-2"],"prefix":"10.3389","volume":"5","author":[{"given":"Tasshitra","family":"Subramaniam","sequence":"first","affiliation":[]},{"given":"Siti Aisyah","family":"Mualif","sequence":"additional","affiliation":[]},{"given":"Weng Howe","family":"Chan","sequence":"additional","affiliation":[]},{"given":"Khairul Bariyyah","family":"Abd Halim","sequence":"additional","affiliation":[]}],"member":"1965","published-online":{"date-parts":[[2025,2,13]]},"reference":[{"key":"B1","doi-asserted-by":"crossref","DOI":"10.1016\/B978-0-323-89775-4.00023-7","article-title":"Chapter 11 - protein structure prediction","volume-title":"Bioinformatics","author":"Agnihotry","year":"2022"},{"key":"B2","doi-asserted-by":"publisher","first-page":"13398","DOI":"10.1038\/s41598-023-40160-2","article-title":"Molecular docking as a tool for the discovery of molecular targets of nutraceuticals in diseases management","volume":"13","author":"Agu","year":"2023","journal-title":"Sci. Rep."},{"key":"B3","doi-asserted-by":"publisher","first-page":"134","DOI":"10.3390\/biology13030134","article-title":"AlphaFold2 reveals structural patterns of seasonal haplotype diversification in SARS-CoV-2 spike protein variants","volume":"13","author":"Ali","year":"2024","journal-title":"Biology"},{"key":"B4","volume-title":"Computational analysis of antibody binding mechanisms to the omicron RBD of SARS-CoV-2 spike protein: identification of epitopes and hotspots for developing effective therapeutic strategies","author":"Alshahrani","year":"2023"},{"key":"B5","doi-asserted-by":"publisher","first-page":"101615","DOI":"10.1016\/j.tmaid.2020.101615","article-title":"Remdesivir as a possible therapeutic option for the COVID-19","volume":"34","author":"Al-Tawfiq","year":"2020","journal-title":"Travel Med. Infect. Dis."},{"key":"B7","doi-asserted-by":"publisher","first-page":"9167","DOI":"10.3390\/ijms21239167","article-title":"Establishment of murine hybridoma cells producing antibodies against spike protein of SARS-CoV-2","volume":"21","author":"Antipova","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"B8","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1056\/nejmoa2204919","article-title":"Nirmatrelvir use and severe covid-19 outcomes during the omicron surge","volume":"387","author":"Arbel","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"B9","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.jiph.2023.02.009","article-title":"Identifying non-nucleoside inhibitors of RNA-dependent RNA-polymerase of SARS-CoV-2 through per-residue energy decomposition-based pharmacophore modeling, molecular docking, and molecular dynamics simulation","volume":"16","author":"Aziz","year":"2023","journal-title":"J. Infect. Public Health"},{"key":"B10","volume-title":"Molecular dynamics simulations: concept, methods, and applications","author":"Badar","year":"2022"},{"key":"B11","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1093\/nar\/28.1.45","article-title":"The SWISS-PROT protein sequence database and its supplement TrEMBL in 2000","volume":"28","author":"Bairoch","year":"2000","journal-title":"Nucleic Acids Res."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1056\/nejmoa2007764","article-title":"Remdesivir for the treatment of covid-19 - final report","volume":"383","author":"Beigel","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1038\/s41598-020-58320-z","article-title":"Mutual population-shift driven antibody-peptide binding elucidated by molecular dynamics simulations","volume":"10","author":"Bekker","year":"2020","journal-title":"Sci. Rep."},{"key":"B14","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1002\/pro.3805","article-title":"Developments, applications, and prospects of cryo-electron microscopy","volume":"29","author":"Benjin","year":"2020","journal-title":"Protein Sci."},{"key":"B15","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/0010-4655(95)00042-e","article-title":"GROMACS: a message-passing parallel molecular dynamics implementation","volume":"91","author":"Berendsen","year":"1995","journal-title":"Comput. Phys. Commun."},{"key":"B16","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/s0022-2836(77)80200-3","article-title":"The Protein Data Bank: a computer-based archival file for macromolecular structures","volume":"112","author":"Bernstein","year":"1977","journal-title":"J. Mol. Biol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1016\/j.csbj.2022.04.038","article-title":"Computational approach for binding prediction of SARS-CoV-2 with neutralizing antibodies","volume":"20","author":"Beshnova","year":"2022","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"B18","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1002\/prot.26422","article-title":"De novo design and Rosetta-based assessment of high-affinity antibody variable regions (Fv) against the SARS-CoV-2 spike receptor binding domain (RBD)","volume":"91","author":"Boorla","year":"2023","journal-title":"Proteins"},{"key":"B19","doi-asserted-by":"crossref","DOI":"10.1016\/B978-0-444-64225-7.00010-9","article-title":"Chapter 10 - structural biology techniques: X-ray crystallography, cryo-electron microscopy, and small-angle X-ray scattering","volume-title":"Practical approaches to biological inorganic chemistry","author":"Brito","year":"2020"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1002\/jcc.21287","article-title":"CHARMM: the biomolecular simulation program","volume":"30","author":"Brooks","year":"2009","journal-title":"J. Comput. Chem."},{"key":"B21","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1002\/prot.10389","article-title":"ZDOCK: an initial\u2010stage protein\u2010docking algorithm","volume":"52","author":"Chen","year":"2003","journal-title":"Proteins Struct. Funct. Bioinforma."},{"key":"B22","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1038\/s41588-022-01033-y","article-title":"Global landscape of SARS-CoV-2 genomic surveillance and data sharing","volume":"54","author":"Chen","year":"2022","journal-title":"Nat. Genet."},{"key":"B23","doi-asserted-by":"crossref","DOI":"10.1101\/2020.11.24.395079","volume-title":"A monoclonal antibody against staphylococcal enterotoxin B superantigen inhibits SARS-CoV-2 entry","author":"Cheng","year":"2020"},{"key":"B24","doi-asserted-by":"publisher","first-page":"710","DOI":"10.3390\/cryst13040710","article-title":"Crystal structure of a chimeric antigen receptor (CAR) scFv domain rearrangement forming a VL-VL dimer","volume":"13","author":"Cheung","year":"2023","journal-title":"Crystals"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1002\/prot.22658","article-title":"FREAD revisited: accurate loop structure prediction using a database search algorithm","volume":"78","author":"Choi","year":"2010","journal-title":"Proteins"},{"key":"B26","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1016\/0022-2836(87)90412-8","article-title":"Canonical structures for the hypervariable regions of immunoglobulins","volume":"196","author":"Chothia","year":"1987","journal-title":"J. Mol. Biol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"782506","DOI":"10.3389\/fimmu.2021.782506","article-title":"In silico analyses on the comparative potential of therapeutic human monoclonal antibodies against newly emerged SARS-CoV-2 variants bearing mutant spike protein","volume":"12","author":"Das","year":"2022","journal-title":"Front. Immunol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3390\/antib12010017","article-title":"Comparative binding ability of human monoclonal antibodies against Omicron variants of SARS-CoV-2: an in silico investigation","volume":"12","author":"Das","year":"2023","journal-title":"Antibodies"},{"key":"B29","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1021\/ar00032a005","article-title":"Antibody structure","volume":"26","author":"Davies","year":"1993","journal-title":"Accounts Chem. Res."},{"key":"B130","doi-asserted-by":"crossref","first-page":"4278","DOI":"10.1093\/bioinformatics\/btac530","article-title":"Prediction of HIV sensitivity to monoclonal antibodies using aminoacid sequences and deep learning","volume":"38","author":"D\u0103n\u0103il\u0103","year":"2022","journal-title":"Bioinformatics"},{"key":"B30","doi-asserted-by":"publisher","first-page":"513237","DOI":"10.1101\/2022.10.21.513237","article-title":"Computationally restoring the potency of a clinical antibody against SARS-CoV-2 Omicron subvariants","author":"Desautels","year":"2023","journal-title":"bioRxiv"},{"key":"B133","first-page":"82","article-title":"Pymol: An open-source molecular graphics tool. CCP4 Newsl","volume":"40","author":"DeLano","year":"2002","journal-title":"Prote. Crysta."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1021\/ja026939x","article-title":"HADDOCK: a protein-protein docking approach based on biochemical or biophysical information","volume":"125","author":"Dominguez","year":"2003","journal-title":"J. Am. Chem. Soc."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1275999","DOI":"10.3389\/fimmu.2023.1275999","article-title":"Development of anti-PD-L1 antibody based on structure prediction of AlphaFold2","volume":"14","author":"Du","year":"2023","journal-title":"Front. Immunol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1093\/bioinformatics\/btv552","article-title":"ANARCI: antigen receptor numbering and receptor classification","volume":"32","author":"Dunbar","year":"2015","journal-title":"Bioinformatics"},{"key":"B34","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1093\/protein\/gzt020","article-title":"ABangle: characterising the VH-VL orientation in antibodies","volume":"26","author":"Dunbar","year":"2013","journal-title":"Protein Eng. Des. Sel."},{"key":"B131","first-page":"454","article-title":"Structural insights into the broad protection against H1 influenza viruses by a computationally optimized hemagglutinin vaccine","volume":"6","author":"Dzimianski","year":"2023","journal-title":"Communi. Bio."},{"key":"B35","doi-asserted-by":"publisher","first-page":"182","DOI":"10.3389\/fmolb.2020.00182","article-title":"Local and global rigidification upon antibody affinity maturation","volume":"7","author":"Fern\u00e1ndez-Quintero","year":"2020","journal-title":"Front. Mol. Biosci."},{"key":"B36","doi-asserted-by":"publisher","first-page":"830202","DOI":"10.3389\/fviro.2022.830202","article-title":"Predictions of the SARS-CoV-2 omicron variant (B. 1.1. 529) spike protein receptor-binding domain structure and neutralizing antibody interactions","volume":"2","author":"Ford","year":"2022","journal-title":"Front. Virology"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1172027","DOI":"10.3389\/fviro.2023.1172027","article-title":"Predicting changes in neutralizing antibody activity for SARS-CoV-2 XBB. 1.5 using in silico protein modeling","volume":"3","author":"Ford","year":"2023","journal-title":"Front. Virology"},{"key":"B38","doi-asserted-by":"publisher","first-page":"797132","DOI":"10.3389\/fmolb.2022.797132","article-title":"Antigen-antibody complex-guided exploration of the hotspots conferring the immune-escaping ability of the SARS-CoV-2 RBD","volume":"9","author":"Fung","year":"2022","journal-title":"Front. Mol. Biosci."},{"key":"B39","doi-asserted-by":"publisher","first-page":"106562","DOI":"10.1016\/j.isci.2023.106562","article-title":"19n01, a broadly neutralizing antibody against omicron BA.1, BA.2, BA.4\/5, and other SARS-CoV-2 variants of concern","volume":"26","author":"Garc\u00eda-Vega","year":"2023","journal-title":"iScience"},{"key":"B40","doi-asserted-by":"publisher","first-page":"15107","DOI":"10.1038\/s41598-023-42090-5","article-title":"Enhanced antibody-antigen structure prediction from molecular docking using AlphaFold2","volume":"13","author":"Gaudreault","year":"2023","journal-title":"Sci. Rep."},{"key":"B41","doi-asserted-by":"publisher","first-page":"198021","DOI":"10.1016\/j.virusres.2020.198021","article-title":"On the interactions of the receptor-binding domain of SARS-CoV-1 and SARS-CoV-2 spike proteins with monoclonal antibodies and the receptor ACE2","volume":"285","author":"Giron","year":"2020","journal-title":"Virus Res."},{"key":"B42","doi-asserted-by":"publisher","first-page":"100770","DOI":"10.1016\/j.jbc.2021.100770","article-title":"Molnupiravir promotes SARS-CoV-2 mutagenesis via the RNA template","volume":"297","author":"Gordon","year":"2021","journal-title":"J. Biol. Chem."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1930636","DOI":"10.1080\/19420862.2021.1930636","article-title":"A human antibody of potent efficacy against SARS-CoV-2 in rhesus macaques showed strong blocking activity to B.1.351","volume":"13","author":"Gu","year":"2021","journal-title":"mAbs"},{"key":"B44","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s40259-023-00641-2","article-title":"Reducing immunogenicity by design: approaches to minimize immunogenicity of monoclonal antibodies","volume":"38","author":"Harris","year":"2024","journal-title":"BioDrugs"},{"key":"B45","doi-asserted-by":"publisher","first-page":"e15032","DOI":"10.1016\/j.heliyon.2023.e15032","article-title":"Computational design of nanomolar-binding antibodies specific to multiple SARS-CoV-2 variants by engineering a specificity switch of antibody 80R using RosettaAntibodyDesign (RAbD) results in potential generalizable therapeutic antibodies for novel SARS-CoV-2 virus","volume":"9","author":"Hernandez","year":"2023","journal-title":"Heliyon"},{"key":"B134","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0263-7855(96)00018-5","article-title":"VMD: visual molecular dynamics","volume":"14","author":"Humphrey","year":"1996","journal-title":"J. Molecu. Graph."},{"key":"B46","doi-asserted-by":"publisher","first-page":"D227","DOI":"10.1093\/nar\/gkj063","article-title":"The PROSITE database","volume":"34","author":"Hulo","year":"2006","journal-title":"Nucleic Acids Res."},{"key":"B6","unstructured":"COVID-19 Variant Update\n          \n          \n          2024"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.15587\/2519-4852.2023.290318","article-title":"Recent advances in computational drug discovery for therapy against coronavirus SARS-CoV-2","author":"Ivanov","year":"2023","journal-title":"Sci. Pharm. Sci."},{"key":"B48","doi-asserted-by":"crossref","DOI":"10.1007\/978-981-15-8936-2_10","article-title":"In silico approach in drug design and drug discovery: an update","volume-title":"Innovations and implementations of computer aided drug discovery strategies in rational drug design","author":"Jabalia","year":"2021"},{"key":"B49","doi-asserted-by":"publisher","first-page":"2423","DOI":"10.1016\/j.sjbs.2021.01.040","article-title":"Identification of natural compounds as potent inhibitors of SARS-CoV-2 main protease using combined docking and molecular dynamics simulations","volume":"28","author":"Jairajpuri","year":"2021","journal-title":"Saudi J. Biol. Sci."},{"key":"B50","doi-asserted-by":"publisher","first-page":"5944","DOI":"10.1021\/acs.jctc.1c00336","article-title":"Native or non-native protein\u2013protein docking models? Molecular dynamics to the rescue","volume":"17","author":"Jandova","year":"2021","journal-title":"J. Chem. Theory Comput."},{"key":"B51","doi-asserted-by":"publisher","first-page":"135703","DOI":"10.1016\/j.molstruc.2023.135703","article-title":"Synthesis, spectral studies, DFT, biological evaluation, molecular docking and dyeing performance of 1-(4-((2-amino-5-methoxy)diazenyl)phenyl) ethanone complexes with some metallic ions","volume":"1287","author":"Jarad","year":"2023","journal-title":"J. Mol. Struct."},{"key":"B52","doi-asserted-by":"publisher","first-page":"11564","DOI":"10.3390\/ijms241411564","article-title":"Impact of E484Q and L452R mutations on structure and binding behavior of SARS-CoV-2 B. 1.617. 1 using deep learning AlphaFold2, molecular docking and dynamics simulation","volume":"24","author":"Jiao","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"B53","doi-asserted-by":"publisher","first-page":"bbae245","DOI":"10.1093\/bib\/bbae245","article-title":"Accurate prediction of antibody function and structure using bio-inspired antibody language model","volume":"25","author":"Jing","year":"2024","journal-title":"Briefings Bioinforma."},{"key":"B54","article-title":"Sequences of proteins of immunological interest","author":"Kabat","year":"1991"},{"key":"B55","doi-asserted-by":"publisher","first-page":"101057","DOI":"10.1016\/j.nantod.2020.101057","article-title":"Nexus between in silico and in vivo models to enhance clinical translation of nanomedicine","volume":"36","author":"Kashkooli","year":"2021","journal-title":"Nano Today"},{"key":"B56","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1016\/j.pathol.2020.09.006","article-title":"Laboratory biosafety measures involving SARS-CoV-2 and the classification as a Risk Group 3 biological agent","volume":"52","author":"Kaufer","year":"2020","journal-title":"Pathology"},{"key":"B57","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1007\/s40265-022-01731-1","article-title":"Tixagevimab + cilgavimab: first approval","volume":"82","author":"Keam","year":"2022","journal-title":"Drugs"},{"key":"B58","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1038\/s41587-020-0512-5","article-title":"Developing therapeutic monoclonal antibodies at pandemic pace","volume":"38","author":"Kelley","year":"2020","journal-title":"Nat. Biotechnol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"10923","DOI":"10.33263\/briac113.1092310939","article-title":"Structural perspective on molecular interaction of IgG and IgA with spike and envelope proteins of SARS-CoV-2 and its implications to non-specific immunity","volume":"11","author":"Khan","year":"2020","journal-title":"Biointerface Res. Appl. Chem."},{"key":"B60","doi-asserted-by":"publisher","first-page":"108585","DOI":"10.1016\/j.compchemeng.2024.108585","article-title":"Applications of machine learning in antibody discovery, process development, manufacturing and formulation: current trends, challenges, and opportunities","volume":"182","author":"Khuat","year":"2024","journal-title":"Comput. and Chem. Eng."},{"key":"B61","doi-asserted-by":"publisher","first-page":"8145","DOI":"10.1038\/s41598-017-08414-y","article-title":"Structure-based cross-docking analysis of antibody-antigen interactions","volume":"7","author":"Kilambi","year":"2017","journal-title":"Sci. Rep."},{"key":"B62","doi-asserted-by":"publisher","first-page":"3274","DOI":"10.3390\/biomedicines10123274","article-title":"Development and characterization of phage-display-derived novel human monoclonal antibodies against the receptor binding domain of SARS-CoV-2","volume":"10","author":"Kim","year":"2022","journal-title":"Biomedicines"},{"key":"B63","doi-asserted-by":"publisher","first-page":"4699","DOI":"10.1080\/07391102.2023.2222191","article-title":"In silico analysis of the different variable domain oriented single-chain variable fragment antibody-antigen complexes","volume":"42","author":"Ko\u00e7er","year":"2024","journal-title":"J. Biomol. Struct. Dyn."},{"key":"B64","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/256495a0","article-title":"Continuous cultures of fused cells secreting antibody of predefined specificity","volume":"256","author":"K\u00f6hler","year":"1975","journal-title":"Nature"},{"key":"B65","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/nprot.2016.169","article-title":"The ClusPro web server for protein\u2013protein docking","volume":"12","author":"Kozakov","year":"2017","journal-title":"Nat. Protoc."},{"key":"B66","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1080\/19420862.2016.1205773","article-title":"ABodyBuilder: automated antibody structure prediction with data-driven accuracy estimation","volume":"8","author":"Leem","year":"2016","journal-title":"MAbs"},{"key":"B67","doi-asserted-by":"publisher","first-page":"D413","DOI":"10.1093\/nar\/gku1056","article-title":"IMGT\u00ae, the international ImMunoGeneTics information system\u00ae 25 years on","volume":"43","author":"Lefranc","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"B68","doi-asserted-by":"publisher","first-page":"4468","DOI":"10.1038\/s41467-021-24525-7","article-title":"Machine learning based energy-free structure predictions of molecules, transition states, and solids","volume":"12","author":"Lemm","year":"2021","journal-title":"Nat. Commun."},{"key":"B69","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1002\/pro.3633","article-title":"AbRSA: a robust tool for antibody numbering","volume":"28","author":"Li","year":"2019","journal-title":"Protein Sci."},{"key":"B70","doi-asserted-by":"publisher","first-page":"bbac152","DOI":"10.1093\/bib\/bbac152","article-title":"Differential performance of RoseTTAFold in antibody modeling","volume":"23","author":"Liang","year":"2022","journal-title":"Briefings Bioinforma."},{"key":"B71","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1093\/nar\/28.1.257","article-title":"SCOP: a structural classification of proteins database","volume":"28","author":"Lo Conte","year":"2000","journal-title":"Nucleic Acids Res."},{"key":"B72","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1159\/000513438","article-title":"Biosafety requirements for autopsies of patients with COVID-19: example of a BSL-3 autopsy facility designed for highly pathogenic agents","volume":"88","author":"Loibner","year":"2021","journal-title":"Pathobiology"},{"key":"B73","doi-asserted-by":"crossref","DOI":"10.1101\/2021.12.12.472313","volume-title":"Structural models of SARS-CoV-2 Omicron variant in complex with ACE2 receptor or antibodies suggest altered binding interfaces","author":"Lubin","year":"2021"},{"key":"B74","doi-asserted-by":"publisher","first-page":"W233","DOI":"10.1093\/nar\/gkn216","article-title":"The RosettaDock server for local protein\u2013protein docking","volume":"36","author":"Lyskov","year":"2008","journal-title":"Nucleic acids Res."},{"key":"B75","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/j.ijbiomac.2022.11.137","article-title":"DNA binding studies of antifungal drug posaconazole using spectroscopic and molecular docking methods","volume":"225","author":"Madku","year":"2023","journal-title":"Int. J. Biol. Macromol."},{"key":"B76","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.biochi.2021.10.013","article-title":"Unravelling the molecular interactions between the SARS-CoV-2 RBD spike protein and various specific monoclonal antibodies","volume":"193","author":"Mart\u00ed","year":"2022","journal-title":"Biochimie"},{"key":"B77","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1006\/jmbi.1996.0617","article-title":"Structural families in loops of homologous proteins: automatic classification, modelling and application to antibodies","volume":"263","author":"Martin","year":"1996","journal-title":"J. Mol. Biol."},{"key":"B78","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1007\/s00018-020-03580-1","article-title":"Protein structure analysis of the interactions between SARS-CoV-2 spike protein and the human ACE2 receptor: from conformational changes to novel neutralizing antibodies","volume":"78","author":"Mercurio","year":"2021","journal-title":"Cell. Mol. Life Sci."},{"key":"B79","unstructured":"What is in silico?\n          \n          \n            \n              Moore\n              S.\n            \n          \n          \n          2021"},{"key":"B80","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.crimmu.2021.03.002","article-title":"Hybridoma technology: is it still useful?","volume":"2","author":"Moraes","year":"2021","journal-title":"Curr. Res. Immunol."},{"key":"B81","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.csbj.2020.12.037","article-title":"Computational modelling supports that dengue virus envelope antibodies can bind to SARS-CoV-2 receptor binding sites: is pre-exposure to dengue virus protective against COVID-19 severity?","volume":"19","author":"Nath","year":"2021","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"B82","doi-asserted-by":"publisher","first-page":"112986","DOI":"10.1016\/j.colsurfb.2022.112986","article-title":"Towards an optimal monoclonal antibody with higher binding affinity to the receptor-binding domain of SARS-CoV-2 spike proteins from different variants","volume":"221","author":"Neamtu","year":"2023","journal-title":"Colloids Surfaces B Biointerfaces"},{"key":"B83","doi-asserted-by":"publisher","first-page":"134780","DOI":"10.1016\/j.molstruc.2022.134780","article-title":"Synthesis, characterization, molecular docking and network pharmacology of bioactive metallic sulfonamide-isatin ligands against promising drug targets","volume":"1277","author":"Noreen","year":"2023","journal-title":"J. Mol. Struct."},{"key":"B84","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1093\/bib\/bbz095","article-title":"Computational approaches to therapeutic antibody design: established methods and emerging trends","volume":"21","author":"Norman","year":"2019","journal-title":"Briefings Bioinforma."},{"key":"B85","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.humimm.2022.01.004","article-title":"Designing of a bispecific antibody against SARS-CoV-2 spike glycoprotein targeting human entry receptors DPP4 and ACE2","volume":"83","author":"Ojha","year":"2022","journal-title":"Hum. Immunol."},{"key":"B86","first-page":"41","article-title":"An EUA for bebtelovimab for treatment of COVID-19","volume":"64","author":"Orders","year":"2022","journal-title":"Med. Lett. Drugs Ther."},{"key":"B87","doi-asserted-by":"publisher","first-page":"71","DOI":"10.3233\/hab-230014","article-title":"Significance of antibody numbering systems in the development of antibody engineering","volume":"31","author":"Patel","year":"2023","journal-title":"Hum. Antibodies"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.3389\/fviro.2021.815388","article-title":"SARS-CoV-2 and the host cell: a tale of interactions","volume":"1","author":"Pizzato","year":"2022","journal-title":"Front. Virology"},{"key":"B89","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-981-16-1594-8_1","article-title":"Structural and functional properties of proteins","volume-title":"Protein-protein interactions: principles and techniques","author":"Poluri","year":"2021"},{"key":"B90","doi-asserted-by":"publisher","first-page":"17720","DOI":"10.1039\/d4cp01372g","article-title":"Exploring conformational landscapes and binding mechanisms of convergent evolution for the SARS-CoV-2 spike Omicron variant complexes with the ACE2 receptor using AlphaFold2-based structural ensembles and molecular dynamics simulations","volume":"26","author":"Raisinghani","year":"2024","journal-title":"Phys. Chem. Chem. Phys."},{"key":"B91","doi-asserted-by":"publisher","first-page":"D383","DOI":"10.1093\/nar\/gkz827","article-title":"Thera-SAbDab: the therapeutic structural antibody database","volume":"48","author":"Raybould","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"B92","volume-title":"Biochemistry, tertiary protein structure","author":"Rehman","year":"2022"},{"key":"B93","doi-asserted-by":"publisher","first-page":"642","DOI":"10.3390\/biomedicines12030642","article-title":"Broad epitope coverage of therapeutic multi-antibody combinations targeting SARS-CoV-2 boosts in vivo protection and neutralization potency to corner an immune-evading virus","volume":"12","author":"Roodink","year":"2024","journal-title":"Biomedicines"},{"key":"B94","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1038\/s41467-023-36295-5","article-title":"Broadly neutralizing SARS-CoV-2 antibodies through epitope-based selection from convalescent patients","volume":"14","author":"Rouet","year":"2023","journal-title":"Nat. Commun."},{"key":"B95","doi-asserted-by":"publisher","first-page":"167208","DOI":"10.1016\/j.jmb.2021.167208","article-title":"AlphaFold and implications for intrinsically disordered proteins","volume":"433","author":"Ruff","year":"2021","journal-title":"J. Mol. Biol."},{"key":"B96","doi-asserted-by":"publisher","first-page":"e130706","DOI":"10.5812\/tms-130706","article-title":"Bebtelovimab: the FDA-approved monoclonal antibody for treating patients with mild-to-moderate COVID-19","volume":"2","author":"Safarzadeh Kozani","year":"2022","journal-title":"J. Adv. Immunopharmacol."},{"key":"B97","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1006\/jmbi.1993.1626","article-title":"Comparative protein modelling by satisfaction of spatial restraints","volume":"234","author":"\u0160ali","year":"1993","journal-title":"J. Mol. Biol."},{"key":"B98","doi-asserted-by":"publisher","first-page":"eabi7826","DOI":"10.1126\/scitranslmed.abi7826","article-title":"An affinity-enhanced, broadly neutralizing heavy chain\u2013only antibody protects against SARS-CoV-2 infection in animal models","volume":"13","author":"Schepens","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"B100","doi-asserted-by":"publisher","first-page":"3381","DOI":"10.1093\/nar\/gkg520","article-title":"SWISS-MODEL: an automated protein homology-modeling server","volume":"31","author":"Schwede","year":"2003","journal-title":"Nucleic Acids Res."},{"key":"B101","doi-asserted-by":"publisher","first-page":"830527","DOI":"10.3389\/fimmu.2021.830527","article-title":"Omicron: a heavily mutated SARS-CoV-2 variant exhibits stronger binding to ACE2 and potently escapes approved COVID-19 therapeutic antibodies","volume":"12","author":"Shah","year":"2022","journal-title":"Front. Immunol."},{"key":"B102","doi-asserted-by":"publisher","first-page":"113796","DOI":"10.1016\/j.jviromet.2019.113796","article-title":"Generation and molecular docking analysis of specific single-chain variable fragments selected by phage display against the recombinant nucleocapsid protein of fig mosaic virus","volume":"276","author":"Shahmirzaie","year":"2020","journal-title":"J. Virol. Methods"},{"key":"B103","doi-asserted-by":"publisher","first-page":"104851","DOI":"10.1016\/j.compbiomed.2021.104851","article-title":"In silico methods and tools for drug discovery","volume":"137","author":"Shaker","year":"2021","journal-title":"Comput. Biol. Med."},{"key":"B104","doi-asserted-by":"publisher","first-page":"424","DOI":"10.3390\/ph17040424","article-title":"Iterative in silico screening for optimizing stable conformation of anti-SARS-CoV-2 nanobodies","volume":"17","author":"Shang","year":"2024","journal-title":"Pharmaceuticals"},{"key":"B105","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1126\/science.1187409","article-title":"Atomic-level characterization of the structural dynamics of proteins","volume":"330","author":"Shaw","year":"2010","journal-title":"Science"},{"key":"B106","doi-asserted-by":"crossref","DOI":"10.1007\/978-981-15-6815-2_7","article-title":"Molecular dynamics simulation of protein and protein\u2013ligand complexes","volume-title":"Computer-aided drug design","author":"Shukla","year":"2020"},{"key":"B107","doi-asserted-by":"publisher","first-page":"4827","DOI":"10.1021\/acs.jcim.1c01114","article-title":"AlphaFold 2: why it works and its implications for understanding the relationships of protein sequence, structure, and function","volume":"61","author":"Skolnick","year":"2021","journal-title":"J. Chem. Inf. Model"},{"key":"B132","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1039\/D3ME00059A","article-title":"Multifaceted mutational immunotherapeutic approach to design therapeutic mAbs to combat monkeypox disease via integrated screening algorithms and antibody engineering","volume":"8","author":"Singh","year":"2023","journal-title":"Molecu. System. Design. Enginee."},{"key":"B108","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1021\/cr960065d","article-title":"Phage display","volume":"97","author":"Smith","year":"1997","journal-title":"Chem. Rev."},{"key":"B109","doi-asserted-by":"publisher","first-page":"106654","DOI":"10.1016\/j.intimp.2020.106654","article-title":"An approach towards development of monoclonal IgY antibodies against SARS CoV-2 spike protein (S) using phage display method: a review","volume":"85","author":"Somasundaram","year":"2020","journal-title":"Int. Immunopharmacol."},{"key":"B110","doi-asserted-by":"publisher","first-page":"3401","DOI":"10.3390\/ijms19113401","article-title":"Role of computational methods in going beyond X-ray crystallography to explore protein structure and dynamics","volume":"19","author":"Srivastava","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"B111","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.hlife.2024.02.001","article-title":"A human monoclonal antibody neutralizes SARS-CoV-2 Omicron variants by targeting the upstream region of spike protein HR2 motif","volume":"2","author":"Su","year":"2024","journal-title":"hLife"},{"key":"B112","doi-asserted-by":"publisher","first-page":"e178880","DOI":"10.1172\/JCI178880","article-title":"Structural characterization of human monoclonal antibodies targeting uncommon antigenic sites on spike glycoprotein of SARS-CoV","author":"Suryadevara","year":"2024","journal-title":"J. Clin. Investigation"},{"key":"B113","doi-asserted-by":"publisher","first-page":"D204","DOI":"10.1093\/nar\/gku989","article-title":"UniProt: a hub for protein information","volume":"43","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"B114","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1002\/jcc.20291","article-title":"GROMACS: fast, flexible, and free","volume":"26","author":"Van Der Spoel","year":"2005","journal-title":"J. Comput. Chem."},{"key":"B115","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1002\/jmr.2394","article-title":"Specificity, polyspecificity, and heterospecificity of antibody-antigen recognition","volume":"27","author":"Van Regenmortel","year":"2014","journal-title":"J. Mol. Recognit."},{"key":"B116","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1002\/jcc.20035","article-title":"Development and testing of a general amber force field","volume":"25","author":"Wang","year":"2004","journal-title":"J. Comput. Chem."},{"key":"B117","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.virs.2022.12.007","article-title":"Hybridoma-derived neutralizing monoclonal antibodies against Beta and Delta variants of SARS-CoV-2 in vivo","volume":"38","author":"Wang","year":"2023","journal-title":"Virol. Sin."},{"key":"B118","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1016\/j.immuni.2022.03.019","article-title":"A large-scale systematic survey reveals recurring molecular features of public antibody responses to SARS-CoV-2","volume":"55","author":"Wang","year":"2022","journal-title":"Immunity"},{"key":"B119","doi-asserted-by":"publisher","first-page":"3959","DOI":"10.1021\/acs.jctc.9b01208","article-title":"Comprehensive evaluation of fourteen docking programs on protein-peptide complexes","volume":"16","author":"Weng","year":"2020","journal-title":"J. Chem. Theory Comput."},{"key":"B120","doi-asserted-by":"publisher","first-page":"W322","DOI":"10.1093\/nar\/gkz397","article-title":"HawkDock: a web server to predict and analyze the protein\u2013protein complex based on computational docking and MM\/GBSA","volume":"47","author":"Weng","year":"2019","journal-title":"Nucleic acids Res."},{"key":"B121","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/978-1-0716-1450-1_4","article-title":"Assessment of therapeutic antibody developability by combinations of in vitro and in silico methods","volume":"2313","author":"Wolf P\u00e9rez","year":"2022","journal-title":"Methods Mol. Biol."},{"key":"B122","doi-asserted-by":"publisher","first-page":"2454","DOI":"10.3389\/fimmu.2019.02454","article-title":"Comparative analysis of the CDR loops of antigen receptors","volume":"10","author":"Wong","year":"2019","journal-title":"Front. Immunol."},{"key":"B123","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1038\/s41586-021-03676-z","article-title":"Nanobodies from camelid mice and llamas neutralize SARS-CoV-2 variants","volume":"595","author":"Xu","year":"2021","journal-title":"Nature"},{"key":"B124","first-page":"1","volume-title":"Computational design and modeling of nanobodies toward SARS\u2010CoV\u20102 receptor binding domain","author":"Yang","year":"2021"},{"key":"B125","doi-asserted-by":"publisher","first-page":"e17846","DOI":"10.7717\/peerj.17846","article-title":"Screening and affinity optimization of single domain antibody targeting the SARS-CoV-2 nucleocapsid protein","volume":"12","author":"Yang","year":"2024","journal-title":"PeerJ"},{"key":"B126","doi-asserted-by":"publisher","first-page":"e4379","DOI":"10.1002\/pro.4379","article-title":"Benchmarking AlphaFold for protein complex modeling reveals accuracy determinants","volume":"31","author":"Yin","year":"2022","journal-title":"Protein Sci."},{"key":"B127","doi-asserted-by":"publisher","first-page":"186","DOI":"10.3390\/v14020186","article-title":"Structure based affinity maturation and characterizing of SARS-CoV antibody CR3022 against SARS-CoV-2 by computational and experimental approaches","volume":"14","author":"Yu","year":"2022","journal-title":"Viruses"},{"key":"B128","doi-asserted-by":"publisher","first-page":"52","DOI":"10.3390\/antib12030052","article-title":"Recent progress in antibody epitope prediction","volume":"12","author":"Zeng","year":"2023","journal-title":"Antibodies (Basel)"},{"key":"B129","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/j.immuni.2023.02.005","article-title":"Broadly neutralizing anti-S2 antibodies protect against all three human betacoronaviruses that cause deadly disease","volume":"56","author":"Zhou","year":"2023","journal-title":"Immunity"}],"container-title":["Frontiers in Bioinformatics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fbinf.2025.1533983\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T07:09:07Z","timestamp":1739430547000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fbinf.2025.1533983\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,13]]},"references-count":133,"alternative-id":["10.3389\/fbinf.2025.1533983"],"URL":"https:\/\/doi.org\/10.3389\/fbinf.2025.1533983","relation":{},"ISSN":["2673-7647"],"issn-type":[{"value":"2673-7647","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,13]]},"article-number":"1533983"}}